Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.
about
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infectionMetabolic factors and chronic hepatitis C: a complex interplayFemale gender in the setting of liver transplantationOvarian senescence increases liver fibrosis in humans and zebrafish with steatosis.The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic PatientsSex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseasesReproductive status is associated with the severity of fibrosis in women with hepatitis C.Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women.Subgroup differences in response to 8 weeks of ledipasvir/sofosbuvir for chronic hepatitis CPatterns of hepatitis C virus RNA levels during acute infection: the InC3 study.How sex and age affect immune responses, susceptibility to infections, and response to vaccinationHepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.Predictive factors associated with hepatitis C antiviral therapy response.Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 studyThe impact of host factors on management of hepatitis C virus.Female Sex Hormones Pattern and Its Relation to Disease Severity and Treatment in Pre- and Postmenopausal Patients with Chronic Hepatitis C Virus (Genotype 4) InfectionBaseline serum cholesterol is associated with a response to pegylated interferon alfa-2b and ribavirin therapy for chronic hepatitis C genotype 2.Symptomatic menopausal transition increases the risk of new-onset depressive disorder in later life: a nationwide prospective cohort study in Taiwan.Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studiesTranslating pharmacogenetics into clinical practice: interleukin (IL)28B and inosine triphosphatase (ITPA) polymophisms in hepatitis C virus (HCV) infection.Current understanding of insulin resistance in hepatitis C.Metabolic alterations and chronic hepatitis C: treatment strategies.Influence of age and gender before and after liver transplantation.Sex hormones and HCV: an unresolved mystery.Psychological, lifestyle and social predictors of hepatitis C treatment response: a systematic review.Review article: the management of cirrhosis in women.Sexual dimorphism in immunity: improving our understanding of vaccine immune responses in men.Cytokines and HCV-related autoimmune disorders.Hepatitis C Infection in the Elderly.Why do I treat my patients with mild hepatitis C?Use of antimüllerian hormone to predict the menopausal transition in HIV-infected women.The role played by gender in viral hepatitis.Natural history and management of hepatitis C: does sex play a role?The impact of antihyperlipidemic drugs on the viral load of patients with chronic hepatitis C infection: a meta-analysis.Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis.Liver disease in menopause.Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients.Prediction of a favorable clinical course in hepatitis C virus carriers with persistently normal serum alanine aminotransferase levels: A long-term follow-up study.Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis.Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C.
P2860
Q26830844-05943F35-D1EB-4646-BAE1-71C940684A8AQ27011787-38D083EE-91F4-4598-827A-9A02213B0CFAQ28087784-689965C2-1C1D-4B57-87D9-269388983435Q30402192-7BD03FE9-8DF7-4C44-8E48-D3C7612C7CDCQ33844403-EA50FB90-90FB-42F1-B8D1-24AE92331674Q33997400-0C810EEA-D948-4E0E-8A58-9DF0DEDB2EDBQ34412627-750125F4-959B-4B66-ADE3-0AA9FF552425Q34589830-B6C71583-6E44-4E37-AE1F-2C91B89EE254Q35072099-EDA98ACE-A4E4-4EF2-894B-722043E27D33Q35249648-3822B984-464B-4675-A2FC-994B55310301Q35527150-A8ABF0E0-BF42-4F61-81D3-78CDA3F57D2EQ35668307-2021E32E-5376-41DD-A73F-33C527413437Q35790397-2A2F10A3-3229-4241-BAEB-78427ABC70C0Q35832850-F18749E2-4B2A-4BEE-AEB2-E8FF1B415A19Q35990066-75BB6679-0829-4F4C-BEBC-2FF3B032FA84Q36112618-81C90879-2BB0-4264-86D3-36842A0FE67EQ36410947-7111A93E-E440-47E3-8203-028C674B4618Q36721136-A09C2C42-39FE-4227-A618-FE2BBB94027BQ36761430-7BD7DA17-804C-4764-92E8-A8F849B91E59Q37879701-0927D72E-0532-479E-8298-89EED73E5F28Q37903853-79335C93-291F-4253-AF8A-7BAF16A765E4Q37924816-8244C4DB-6FEC-4817-A616-33F83284044BQ38061619-C9F43531-30B9-4B85-A926-50A0D310A273Q38069609-DB29E880-5579-4FE3-B38F-6701A8171BFCQ38098579-895DA6C9-C784-46D4-BC6A-82C1671BDE34Q38255043-E688A04C-7ACD-43B2-902E-1367F7DAD8ADQ38256290-5ABD16B1-11A5-40E1-935A-91D1129B3A34Q38266253-103ED6F3-B567-4AA6-AE5B-24FDF58FEAA4Q38501726-A8D05929-5839-4B7B-99A6-0884F3B49546Q38685564-268AAF1F-C8EF-418C-A2B4-9A1BA9C3A758Q39544986-DBB8FBA0-EB0F-4A02-BA49-434BCAF5CAA1Q42202432-56E28308-CBE9-4456-98DC-6E03D498EA52Q42208880-839B4C2C-CE59-41F7-809C-EEF1DE4B03AEQ42211503-8594E56E-806B-4D03-A1BF-FA1FDA0BBAD2Q42259157-5F20FBE0-4378-44AB-968D-D5F68E027927Q42359764-5A424522-266C-43DB-ABF0-8AB50A61311AQ42977889-101C9660-1087-4508-82A3-F8D1CF9E8B9CQ45354798-8AA6A248-C95B-4479-AF3E-77AC79D76924Q46772423-ECF54E9B-123F-4E84-985A-3CE2BAB2B5E1Q50551487-39FADDC5-E9B1-459D-BDE2-7E595835C775
P2860
Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Early menopause is associated ...... omen with chronic hepatitis C.
@en
Early menopause is associated ...... omen with chronic hepatitis C.
@nl
type
label
Early menopause is associated ...... omen with chronic hepatitis C.
@en
Early menopause is associated ...... omen with chronic hepatitis C.
@nl
prefLabel
Early menopause is associated ...... omen with chronic hepatitis C.
@en
Early menopause is associated ...... omen with chronic hepatitis C.
@nl
P2093
P50
P1433
P1476
Early menopause is associated ...... omen with chronic hepatitis C.
@en
P2093
Aimilia Karampatou
Alessandro Antonelli
Amalia Graziosi
Anna Ferrari
Antonio Francavilla
Barbara Lei
Calogero Cammà
Gloria Taliani
Luisa Losi
Maria Rendina
P304
P356
10.1053/J.GASTRO.2010.12.027
P407
P577
2010-12-16T00:00:00Z